Dogma Therapeutics jobs and careers

dogmatherapeutics.com LinkedIn

About Dogma Therapeutics

Dogma is developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. https://www.dogmatherapeutics.com/

Founded in 2017 by Doug Daniels.

Biotechnology Pharmaceutical

Founded: 2017
Employees: 1 to 10
Total funding: $3.5M

Leadership

The top of Dogma Therapeutics's org chart, with how many people report into each leader.

PS

Pascal Soriot

CEO

5,884 reports

DF

David Fredrickson

EVP, Global Head Oncology Business Unit

2,204 reports

RD

Ruud Dobber

EVP & President, BioPharmaceuticals Business

1,768 reports

SG

Susan Galbraith

EVP, Oncology R&D

732 reports

PC

Pam Cheng

EVP, Operations & IT

441 reports

HG

Harsh Gandhi

Chief Digital & Information Officer, Astrazeneca Japan

356 reports

AM

Anthony M.

Senior Vice President, Head Of Quality (cqo)

84 reports

RI

Renee Iacona

Chief Operating Officer - Oncology R&D

76 reports

JP

Jeff Pott

Chief Human Resources Officer, Chief Compliance Officer and General Counsel

75 reports

Board

MW

Marcus Wallenberg

Director

MD

Michel Demaré

Chair

TM

Tony Mok

Director

EA

Euan Ashley

Non-Executive Director

DL

Diana Layfield

Non-Executive Director

BC

Birgit Conix

Director

Jobs at Dogma Therapeutics

No open positions right now. Explore more companies on TheJobsMap.